3.20
price up icon0.31%   0.01
 
loading
Precedente Chiudi:
$3.19
Aprire:
$3.14
Volume 24 ore:
2,487
Relative Volume:
0.14
Capitalizzazione di mercato:
$16.10M
Reddito:
-
Utile/perdita netta:
$-16.35M
Rapporto P/E:
-1.0492
EPS:
-3.05
Flusso di cassa netto:
$-11.88M
1 W Prestazione:
+6.31%
1M Prestazione:
-2.44%
6M Prestazione:
-42.34%
1 anno Prestazione:
-33.30%
Intervallo 1D:
Value
$3.05
$3.2899
Intervallo di 1 settimana:
Value
$3.01
$3.3616
Portata 52W:
Value
$2.75
$11.79

Lipocine Inc Stock (LPCN) Company Profile

Name
Nome
Lipocine Inc
Name
Telefono
801 994 7383
Name
Indirizzo
675 ARAPEEN DRIVE, SUITE 202, SALT LAKE CITY, UT
Name
Dipendente
16
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-06
Name
Ultimi documenti SEC
Name
LPCN's Discussions on Twitter

Confronta LPCN con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
LPCN
Lipocine Inc
3.2899 16.10M 0 -16.35M -11.88M -3.05
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
492.64 122.76B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
606.43 61.38B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
616.17 36.37B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
253.46 30.12B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
250.00 24.70B 3.81B -644.79M -669.77M -6.24

Lipocine Inc Stock (LPCN) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2021-06-24 Iniziato Cantor Fitzgerald Overweight
2020-12-10 Aggiornamento Ladenburg Thalmann Neutral → Buy
2018-01-12 Reiterato H.C. Wainwright Buy
2018-01-11 Downgrade Canaccord Genuity Buy → Hold
2017-12-08 Ripresa H.C. Wainwright Buy
2016-10-07 Iniziato H.C. Wainwright Buy
2015-07-22 Iniziato ROTH Capital Buy
2015-06-23 Iniziato Canaccord Genuity Buy
Mostra tutto

Lipocine Inc Borsa (LPCN) Ultime notizie

pulisher
04:32 AM

Press Release Distribution & PR Platform - ACCESS Newswire

04:32 AM
pulisher
Apr 24, 2025

Sarcopenia Clinical Trial Pipeline Appears Robust With 18+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - GlobeNewswire Inc.

Apr 24, 2025
pulisher
Apr 23, 2025

StockNews.com Begins Coverage on Lipocine (NASDAQ:LPCN) - Defense World

Apr 23, 2025
pulisher
Apr 18, 2025

Lipocine Receives Updated Regulatory Guidance on LPCN 1154 (PR Newswire) - Aktiellt

Apr 18, 2025
pulisher
Apr 15, 2025

Lipocine (NASDAQ:LPCN) Coverage Initiated by Analysts at StockNews.com - Defense World

Apr 15, 2025
pulisher
Apr 07, 2025

Lipocine (NASDAQ:LPCN) Coverage Initiated at StockNews.com - Defense World

Apr 07, 2025
pulisher
Apr 03, 2025

Lipocine Inc. Reports 2024 Financial Turnaround - TipRanks

Apr 03, 2025
pulisher
Mar 27, 2025

Lipocine’s Phase III trial of LPCN 1154 to begin for postpartum depression - Yahoo

Mar 27, 2025
pulisher
Mar 26, 2025

Lipocine Announces Initiation of Outpatient Phase 3 Postpartum Depression Trial of LPCN 1154 - MarketScreener

Mar 26, 2025
pulisher
Mar 22, 2025

StockNews.com Initiates Coverage on Lipocine (NASDAQ:LPCN) - Defense World

Mar 22, 2025
pulisher
Mar 21, 2025

Testosterone, TRAVERSE, And A Label Change 15 Years In The Making - News & Insights

Mar 21, 2025
pulisher
Mar 13, 2025

Lipocine Announces Financial Results for the Full Year Ended December 31, 2024 - Quantisnow

Mar 13, 2025
pulisher
Mar 13, 2025

Lipocine Turns Profitable: How $11.2M in Licensing Deals Transformed 2024 Results - StockTitan

Mar 13, 2025
pulisher
Mar 12, 2025

Lipocine to change FDA labeling for testosterone products -March 12, 2025 at 09:59 am EDT - Marketscreener.com

Mar 12, 2025
pulisher
Mar 12, 2025

Lipocine Announces FDA Labeling Changes for Testosterone Products - Citizentribune

Mar 12, 2025
pulisher
Mar 12, 2025

Lipocine announces FDA labeling changes for testosterone products - TipRanks

Mar 12, 2025
pulisher
Mar 12, 2025

FDA Lifts Critical Cardiovascular Warning for Testosterone Treatments: Major Win for Lipocine - StockTitan

Mar 12, 2025
pulisher
Mar 06, 2025

Lipocine (NASDAQ:LPCN) Now Covered by Analysts at StockNews.com - The AM Reporter

Mar 06, 2025
pulisher
Mar 04, 2025

LPCN stock touches 52-week low at $2.92 amid market challenges By Investing.com - Investing.com South Africa

Mar 04, 2025
pulisher
Mar 04, 2025

LPCN stock touches 52-week low at $2.92 amid market challenges - Investing.com UK

Mar 04, 2025
pulisher
Mar 03, 2025

Lipocine Inc expected to post a loss of 40 cents a shareEarnings Preview - TradingView

Mar 03, 2025
pulisher
Mar 01, 2025

Lipocine to Host Virtual KOL Event on LPCN 2401 for Improved Body Composition in Obesity Management on October 16, 2024 - Marketscreener.com

Mar 01, 2025
pulisher
Feb 27, 2025

Lipocine (LPCN) Expected to Announce Earnings on Thursday - Defense World

Feb 27, 2025
pulisher
Feb 26, 2025

Lipocine (NASDAQ:LPCN) Now Covered by StockNews.com - Defense World

Feb 26, 2025
pulisher
Feb 11, 2025

Lipocine Updates Corporate Presentation in Recent 8-K Filing - Defense World

Feb 11, 2025
pulisher
Feb 08, 2025

Lipocine (NASDAQ:LPCN) Receives Updated Regulatory Guidance for LPCN 1154 - Defense World

Feb 08, 2025
pulisher
Feb 07, 2025

Lipocine plans phase 3 study for postpartum depression drug - MSN

Feb 07, 2025
pulisher
Feb 06, 2025

Lipocine Inc. Receives Updated Regulatory Guidance on LPCN 1154 -February 06, 2025 at 09:30 am EST - Marketscreener.com

Feb 06, 2025
pulisher
Feb 06, 2025

Lipocine plans phase 3 study for postpartum depression drug By Investing.com - Investing.com South Africa

Feb 06, 2025
pulisher
Feb 06, 2025

Lipocine Receives Updated Regulatory Guidance on LPCN 1154 - The Herald Journal

Feb 06, 2025
pulisher
Feb 02, 2025

Lipocine (NASDAQ:LPCN) Earns Hold Rating from Analysts at StockNews.com - Defense World

Feb 02, 2025
pulisher
Jan 28, 2025

Postpartum Depression Market Expected to rise, 2034 | Pfizer, Sage Therapeutics, Lipocine Inc, Eli Lilly and Company, GSK, Canopie, Talkspace, expected to drive market - Barchart

Jan 28, 2025
pulisher
Jan 20, 2025

Lipocine Updates Corporate Presentation, Files 8-K with SEC - Defense World

Jan 20, 2025
pulisher
Jan 12, 2025

(LPCN) On The My Stocks Page - Stock Traders Daily

Jan 12, 2025

Lipocine Inc Azioni (LPCN) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$20.65
price up icon 0.63%
$70.47
price up icon 1.28%
$32.49
price up icon 0.64%
$23.90
price up icon 1.85%
$108.35
price up icon 3.89%
biotechnology ONC
$247.87
price up icon 1.21%
Capitalizzazione:     |  Volume (24 ore):